Enrolled patients will be recruited to two parallel groups during therapy for Hepatitis C. Patients in the first one will receive a patient assistance program, and patients in the second group will not. All patients will receive PegIntron and Rebetol according to label.
Non-Probability Sample, Commercial product used according to EU label.
Study Type
OBSERVATIONAL
Enrollment
99
Peginterferon alfa-2b will be administered according to the product's labeling.
Ribavirin will be administered according to the product's labeling.
The patient assistance program includes the following: * Training by physicians or specialized nurses. * Informational materials based on the "To beat HCV" program. * Management of specific side effects.
The Number of Participants Who Complete Treatment With PegIntron/Rebetol Therapy for Hepatitis C
Participant adherence to therapy was compared between participants treated with PegIntron/Rebetol either with or without a patient assistance program
Time frame: At the end of the 48-week treatment period
The Number of Participants With a Sustained Virologic Response at 6 Months Post-treatment
Sustained virologic response is defined as having an undetectable hepatitis C virus ribonucleic acid (HCV-RNA) at the end of treatment and 6 months post-treatment
Time frame: Measured at 6 months post-treatment
The Number of Participants Who Relapsed at 6 Months Post-treatment
Participants who relapse are defined as having an undetectable HCV-RNA at the end of treatment but detectable HCV-RNA at 6 months post-treatment
Time frame: Measured at end of treatment and 6 months post-treatment
Average Length of Treatment
Participant adherence to therapy was compared between participants who received vs not received a patient assistance program in addition to their PegIntron/Rebetol treatment.
Time frame: Maximum 48-week treatment duration
Average Dosage of PegIntron
Dosage of PegIntron was expressed in terms of micrograms of PegIntron received per kilogram of participant's body weight per week
Time frame: Up to 48-week treatment duration
Average Dosage of Rebetol
Rebetol dosage was expressed in milligrams per kilogram of body weight per day.
Time frame: Up to 48-week treatment duration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.